Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/01/21 → 3/01/24 |
Developing SMN2 splice-switching antisense oligonucleotide therapy for MND
- Turner, Bradley J. (Primary Chief Investigator (PCI))
- Shabanpoor, Fazel (Chief Investigator (CI))
- Rogers, Mary-Louise (Chief Investigator (CI))
- Nicolazzo, Joseph (Chief Investigator (CI))
Project: Research